Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 West 4th Ave, Vancouver, Canada

DragonAlgo Mar. 5 at 9:44 PM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2027-01-15 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $1.32 Stop: $0.95 TP1: $1.72 TP2: $2.25 TP3: $3.18 Rules-based execution profile. 🔗 https://dragonalgo.com

0 · Reply

Targhee Mar. 5 at 5:23 PM

$ABCL statement is true enough!…here’s another true one…shorties are feeling the pressure- tick-tick-tick

0 · Reply

TradeWinner Mar. 5 at 4:28 PM

$ABCL Boughta pretty big chunk today. Near recent insider prices seems like a bargain. Valuation should be safe around here even in a tougher market imo.

1 · Reply

tradersunion353 Mar. 5 at 4:03 PM

$ABCL Over hyped underperforming stock Its been 2 plus years without aby returns. Well , people who are planning to hold for a decade please disregard my comment .

0 · Reply

SmallCapTradingFlows Mar. 5 at 2:10 PM

$CLOV $FBIO $TGTX $ABCL Bio

0 · Reply

snowPOW Mar. 5 at 5:52 AM

$BB $ABCL massive, huge, insider buying FLAT share price https://www.nasdaq.com/market-activity/stocks/abcl/insider-activity $GME massive insider buying; 21M bucks. Flat No movement What's the deal?

1 · Reply

TheinvestmetABCD Mar. 4 at 6:07 PM

$ABCL run towards $4 this week hopefully

0 · Reply

Art_BunyaaHa Mar. 4 at 5:28 PM

$ABCL 9 days to cover

0 · Reply

tradersunion353 Mar. 4 at 4:46 PM

$ABCL Such a disappointing performance for last few weeks Earnings were good , insiders are buying still cannot get the blessings from Wall Street

0 · Reply

raccoonblackbear Mar. 4 at 4:28 PM

$ABCL Who will get exhausted first... The buyers or sellers? Definite battleground at 3.70ish right now

0 · Reply

AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 4:05 PM EST - 9 days ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 22 days ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 6 weeks ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 9:16 PM EST - 7 weeks ago

AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 9:00 AM EST - 7 weeks ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 2 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 3 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 8, 2025, 1:37 PM EST - 3 months ago

AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 22, 2025, 12:23 AM EST - 3 months ago

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 10, 2025, 9:00 AM EST - 4 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 7, 2025, 7:16 PM EST - 4 months ago

AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 5 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 6, 2025, 7:35 AM EDT - 5 months ago

AbCellera Biologics: Entering Growth Phase After A Pause

Sep 29, 2025, 4:05 PM EDT - 5 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 6 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Aug 27, 2025, 9:00 AM EDT - 6 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 7:48 PM EDT - 7 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 8 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

May 30, 2025, 1:00 PM EDT - 9 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 10 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 10 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 10 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 10:33 PM EDT - 10 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 10 months ago

AbCellera Reports Q1 2025 Business Results

Apr 29, 2025, 3:00 PM EDT - 11 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Feb 27, 2025, 11:26 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

DragonAlgo Mar. 5 at 9:44 PM

0 · Reply

Targhee Mar. 5 at 5:23 PM

$ABCL statement is true enough!…here’s another true one…shorties are feeling the pressure- tick-tick-tick

0 · Reply

TradeWinner Mar. 5 at 4:28 PM

$ABCL Boughta pretty big chunk today. Near recent insider prices seems like a bargain. Valuation should be safe around here even in a tougher market imo.

1 · Reply

tradersunion353 Mar. 5 at 4:03 PM

$ABCL Over hyped underperforming stock Its been 2 plus years without aby returns. Well , people who are planning to hold for a decade please disregard my comment .

0 · Reply

SmallCapTradingFlows Mar. 5 at 2:10 PM

$CLOV $FBIO $TGTX $ABCL Bio

0 · Reply

snowPOW Mar. 5 at 5:52 AM

$BB $ABCL massive, huge, insider buying FLAT share price https://www.nasdaq.com/market-activity/stocks/abcl/insider-activity $GME massive insider buying; 21M bucks. Flat No movement What's the deal?

1 · Reply

TheinvestmetABCD Mar. 4 at 6:07 PM

$ABCL run towards $4 this week hopefully

0 · Reply

Art_BunyaaHa Mar. 4 at 5:28 PM

$ABCL 9 days to cover

0 · Reply

tradersunion353 Mar. 4 at 4:46 PM

$ABCL Such a disappointing performance for last few weeks Earnings were good , insiders are buying still cannot get the blessings from Wall Street

0 · Reply

raccoonblackbear Mar. 4 at 4:28 PM

$ABCL Who will get exhausted first... The buyers or sellers? Definite battleground at 3.70ish right now

0 · Reply

Kaykay610 Mar. 4 at 3:59 PM

$ABCL good conference and clarification on what they seen with 635 phase 1 that reassured them that they are on the right track!!

0 · Reply

SmallCapTradingFlows Mar. 4 at 2:03 PM

$NKTR $VWAV $ARTV $ABCL ++

1 · Reply

DeMampCamp Mar. 4 at 1:39 PM

$ABCL Happy Hump Day my peeps!! Let's gooooo!!

3 · Reply

JustTheFactsInvesting Mar. 4 at 6:12 AM

$ABCL The man's name is literally Carl Lars Genghis Hansen...seriously. That's a dude you bet on.

1 · Reply

DragonAlgo Mar. 4 at 6:01 AM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $5.00 | Type: CALL Option Plan (premium): Entry: $0.15 Stop: $0.11 TP1: $0.20 TP2: $0.26 TP3: $0.36 🔗 https://dragonalgo.com

0 · Reply

TheinvestmetABCD Mar. 3 at 6:28 PM

$ABCL strong

0 · Reply

Rastafari Mar. 3 at 4:24 PM

$ABCL There’s a good chance we end this week over $4!

1 · Reply

DragonAlgo Mar. 3 at 1:10 PM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-03-20 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.39 TP2: $0.51 TP3: $0.72 🔗 https://dragonalgo.com

0 · Reply

50bps Mar. 2 at 10:51 PM

$ABCL bazinga

0 · Reply

TheinvestmetABCD Mar. 2 at 10:24 PM

$ABCL First major resistance $4,20. If we take that out and backtest succesfully $6 coming

1 · Reply

TheDrunkTrader69 Mar. 2 at 9:44 PM

$ABCL back to 8

0 · Reply

snowPOW Mar. 2 at 9:37 PM

$ABCL nice

0 · Reply

Market Cap	1.12B
Revenue (ttm)	75.13M
Net Income (ttm)	-146.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-194.88%
Debt to Equity Ratio	0.00

Volume	2,326,624
Avg Vol	4,466,834
Day's Range	N/A - N/A
Shares Out	303.16M
Stochastic %K	76%
Beta	0.84
Analysts	Strong Sell
Price Target	$8.43